Bonjesta (20 mg + 20 mg) modified release tablets 20 pcs.

Bonjesta® (Bonjesta)

Modified-release tablets, 20 mg + 20 mgComposition per 1 tablet:

Doxylamine hydrobutartrate — 20 mg

Pyridoxine hydrochloride (vitamin B6) — 20 mg

Release form: Round-shaped, film-coated, modified-release tablets.

There are 10 tablets in a blister.

There are 20 tablets in a cardboard pack.

Pharmacological action:

The drug has an antiemetic effect due to a combination of:

Doxylamine (antihistamine component) — blocks H1-histamine receptors, has a sedative effectPyridoxine (B6) — reduces nausea, participates in amino acid metabolism

The modified release ensures a gradual intake of active substances and a long-lasting effect.Indications for use:

Nausea and vomiting in pregnant women (including severe form — hyperemesis gravidarum), when diet, dietary changes and uncorrectable factors have no effect.

Dosage regimen (typical): It is prescribed only by a doctor

Usually - 1 tablet at night, if necessary — additionally in the morning and afternoon (under the supervision of a doctor)Contraindications: Individual intolerance to the components

Severe liver/kidney dysfunction

Children's age

Simultaneous administration of MAO inhibitors

Side effects: Drowsiness, decreased concentration

Dry mouth, constipation

Dizziness

Storage conditions:

At a temperature not exceeding 25 °C, out of the reach of children

Pharmacy leave: By prescription.

Exeltis Poland Sp.z o.o

Szamocka 8

01-748 Warszawa

📦Find out about the delivery to your country on WhatsApp

Important notice

The photograph is provided for product identification. Packaging design may vary by batch or market. This page provides general product information and does not replace the package leaflet, diagnosis, prescription or advice from a doctor or pharmacist.